{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-21-067652","form_type":"8-K","ticker":"ADTX","cik":"0001726711","company_name":"Aditxt, Inc.","filed_at":"2021-12-28T23:59:59+00:00","discovered_at":"2026-05-14T18:04:13.857188+00:00","generated_at":"2026-06-27T22:10:03.072470+00:00","sec_items":["1.01","5.02","7.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Aditxt to acquire AiPharma in all-stock deal valued at ~44.7M shares plus $500K cash","bullets":["Initial closing by Jan 31, 2022 for 9.5% of AiPharma: 4.8M shares + $250K cash.","Secondary closing for remaining 90.5% subject to shareholder and Nasdaq approval: 39.9M shares + $250K cash.","AiPharma holds exclusive rights to Avigan (favipiravir) for COVID-19; Phase 3 trial missed primary endpoint.","Two board members, Lauren Chung and Laura Anthony, resigned effective Dec 31, 2021; no disagreement cited.","AiPharma has strategic alliance with Appili Therapeutics (TSX:APLI) and plans new global clinical trial for Avigan."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-21-067652","json":"https://secwatch.observer/filing/0001213900-21-067652.json","markdown":"https://secwatch.observer/filing/0001213900-21-067652.md","text":"https://secwatch.observer/filing/0001213900-21-067652.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1726711/000121390021067652/0001213900-21-067652-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1726711/000121390021067652/ea153046-8k425_aditxtinc.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T22:10:03.072470+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"878f9a6b36","claim":"Laura Anthony resigned as Director at Aditxt, Inc..","evidence_excerpt":"On December 26, 2021, Laura Anthony notified the Company that effective December 31, 2021, she is resigning from the Company’s Board of Directors.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1726711/000121390021067652/0001213900-21-067652-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"fa372a8d2a","claim":"Lauren Chung resigned as Director at Aditxt, Inc..","evidence_excerpt":"On December 24, 2021, Lauren Chung notified the Company that effective December 31, 2021, she is resigning from the Company’s Board of Directors.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1726711/000121390021067652/0001213900-21-067652-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}